184 related articles for article (PubMed ID: 9924431)
1. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up.
Lipponen P; Aaltoma S; Kosma VM; Ala-Opas M; Eskelinen M
J Pathol; 1998 Oct; 186(2):157-64. PubMed ID: 9924431
[TBL] [Abstract][Full Text] [Related]
2. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J
Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928
[TBL] [Abstract][Full Text] [Related]
3. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma.
Böhm JP; Niskanen LK; Pirinen RT; Kiraly K; Kellokoski JK; Moisio KI; Eskelinen MJ; Tulla HE; Hollmen S; Alhava EM; Kosma VM
J Pathol; 2000 Nov; 192(3):321-7. PubMed ID: 11054715
[TBL] [Abstract][Full Text] [Related]
4. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.
Kawano T; Nakamura Y; Yanoma S; Kubota A; Furukawa M; Miyagi Y; Tsukuda M
Auris Nasus Larynx; 2004 Mar; 31(1):35-41. PubMed ID: 15041052
[TBL] [Abstract][Full Text] [Related]
5. CD44s and CD44v6 in diagnosis and prognosis of human bladder cancer.
Omran OM; Ata HS
Ultrastruct Pathol; 2012 May; 36(3):145-52. PubMed ID: 22559040
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells.
Kuncová J; Urban M; Mandys V
APMIS; 2007 Nov; 115(11):1194-205. PubMed ID: 18092951
[TBL] [Abstract][Full Text] [Related]
7. CD44s and CD44v6 expression in localized T1-T2 conventional renal cell carcinomas.
Daniel L; Lechevallier E; Giorgi R; Lindner V; De Fromont M; Vieillefond A; Coulange C; Figarella-Branger D
J Pathol; 2001 Mar; 193(3):345-9. PubMed ID: 11241414
[TBL] [Abstract][Full Text] [Related]
8. Expression of cathepsin D in transitional cell bladder tumours.
Lipponen PK
J Pathol; 1996 Jan; 178(1):59-64. PubMed ID: 8778318
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study.
Morris SF; O'Hanlon DM; McLaughlin R; McHale T; Connolly GE; Given HF
Eur J Surg Oncol; 2001 Sep; 27(6):527-31. PubMed ID: 11520083
[TBL] [Abstract][Full Text] [Related]
10. CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression.
Saegusa M; Machida D; Hashimura M; Okayasu I
J Pathol; 1999 Nov; 189(3):326-37. PubMed ID: 10547593
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer.
Müller W; Schneiders A; Heider KH; Meier S; Hommel G; Gabbert HE
J Pathol; 1997 Oct; 183(2):222-7. PubMed ID: 9390037
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
[TBL] [Abstract][Full Text] [Related]
14. CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage?
Regauer S; Ott A; Berghold A; Beham A
J Pathol; 1999 Jan; 187(2):184-90. PubMed ID: 10365093
[TBL] [Abstract][Full Text] [Related]
15. CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis.
Ristamäki R; Joensuu H; Söderström KO; Jalkanen S
J Pathol; 1995 Jul; 176(3):259-67. PubMed ID: 7545748
[TBL] [Abstract][Full Text] [Related]
16. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.
Lipponen PK; Aaltomaa S
J Pathol; 1994 Aug; 173(4):333-9. PubMed ID: 7965393
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
[TBL] [Abstract][Full Text] [Related]
19. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
Lipponen PK; Eskelinen MJ; Kiviranta J; Nordling S
Anticancer Res; 1991; 11(2):911-6. PubMed ID: 2064350
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 protein has no independent prognostic value in breast cancer.
Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
J Pathol; 1995 Nov; 177(3):225-32. PubMed ID: 8551383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]